Patent details

EP2970127 Title: 2,3-DISUBSTITUTED 1-ACYL-4-AMINO-1,2,3,4-TETRAHYDROQUINOLINE DERIVATIVES AND THEIR USE AS BROMODOMAIN INHIBITORS

  • Data
  • Documents

Basic Information

Publication number:
EP2970127
PCT Application Number:
EP2014054795
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP147133946
PCT Publication Number:
WO2014140076
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
2,3-DISUBSTITUTED 1-ACYL-4-AMINO-1,2,3,4-TETRAHYDROQUINOLINE DERIVATIVES AND THEIR USE AS BROMODOMAIN INHIBITORS
French Title of Invention:
DÉRIVÉS DE 1-ACYL-4-AMINO-1,2,3,4-TÉTRAHYDROQUINOLÉINE 2,3-DISUBSTITUÉS ET LEUR UTILISATION EN TANT QU'INHIBITEURS DE BROMODOMAINE
German Title of Invention:
2,3-DISUBSTITUIERTE 1-ACYL-4-AMINO-1,2,3,4-TETRAHYDROQUINOLIN- DERIVATE UND IHRE VERWENDUNG ALS BROMODOMAIN INHIBITOREN
SPC Number:

Dates

Filing date:
12/03/2014
Grant date:
24/10/2018
EP Publication Date:
20/01/2016
PCT Publication Date:
18/09/2014
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
24/10/2018
EP B1 Publication Date:
24/10/2018
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
12/03/2034
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
17/04/2025
 
 

Name:
GLAXOSMITHKLINE INTELLECTUAL PROPERTY (No. 2) LIMITED
Address:
GSK Medicines Research Centre Gunnels Wood Road, SG1 2NY, STEVENAGE, United Kingdom (GB)

History of Owners

From:
17/10/2018
To:
17/04/2025

Name:
GlaxoSmithKline Intellectual Property (No. 2) Limited
Address:
980 Great West Road, Brentford, Middlesex TW8 9GS, United Kingdom (GB)

Agent

Name:
OFFICE FREYLINGER S.A.
From:
12/12/2018
Address:
Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
To:

Inventor

1

Name:
HARRISON, Lee Andrew
Address:
United Kingdom (GB)

2

Name:
WELLAWAY, Christopher Roland
Address:
United Kingdom (GB)

3

Name:
PRESTON, Alexander
Address:
United Kingdom (GB)

4

Name:
LINDON, Matthew
Address:
United Kingdom (GB)

5

Name:
AMANS, Dominique
Address:
United Kingdom (GB)

6

Name:
ATKINSON, Stephen John
Address:
United Kingdom (GB)

7

Name:
SEAL, Jonathan Thomas
Address:
United Kingdom (GB)

8

Name:
LAW, Robert Peter
Address:
United Kingdom (GB)

9

Name:
HIRST, David Jonathan
Address:
United Kingdom (GB)

Priority

1

Priority Number:
201361781583 P
Priority Date:
14/03/2013
Priority Country:
United States (US)

2

Priority Number:
201361882798 P
Priority Date:
26/09/2013
Priority Country:
United States (US)

Classification

IPC classification:
A61K 31/4375; A61K 31/4706; A61K 31/4709; C07D 215/227; C07D 215/44; C07D 215/46; C07D 215/48; C07D 401/04; C07D 401/12; C07D 401/14; C07D 405/04; C07D 405/14; C07D 409/12; C07D 409/14; C07D 413/04;

Publication

Bulletin

Bulletin Heading:
CO
Bulletin edition number:
2025/07
Publication date:
04/06/2025
Description:
Section M : Transfers of property (Art. 53 of the law), change of name and/or address

European Patent Bulletin

1

Issue number:
201843
Publication date:
24/10/2018
Description:
Grant (B1)

2

Issue number:
201848
Publication date:
28/11/2018
Description:
Application number/publication number of the divisional application (Art. 76) changed

Deed

Change of owner(s)

Change Kind/ Decision Type:
Change of owner(s) name/address
Deed Number:
RC20250000148A
Date Registered:
17/04/2025
Licence Effective Date:
Licence Expiration Date:
Scope of Licence:
Deed Filer:
ARONOVA S.A.
Journal Edition Number:
Text:
Country Code:
Updated Licence Number:
Terminated Licence Number:

Added Owner(s)

Name:
GLAXOSMITHKLINE INTELLECTUAL PROPERTY (No. 2) LIMITED
Address:
GSK Medicines Research Centre Gunnels Wood Road, SG1 2NY, STEVENAGE, United Kingdom (GB)
Name:
Address:

Annual Fees

Annual Fee Due Date:
31/03/2026
Annual Fee Number:
13
Annual Fee Amount:
180 Euro
Expected Payer:
Last Annual Fee Payment Date:
21/03/2025
Last Annual Fee Paid Number:
12
Last Annual Fee Paid Amount:
165 Euro
Payer:
IP CENTRUM LIMITED